e present invention relates to aryl triazole derivs. of Formula I having antitumoral activity through, as one possible biol. target, the mol. chaperone heat shock protein 90 (Hsp90) inhibition. The invention includes the use of such compds. in medicine, in relation to cancer disease as well as other diseases where an inhibition of Hsp90 is responsive, and the pharmaceutical compn. contg. such compds
Giannini, G., Cabri, W., Vesci, L., Cervoni, M.L., Pisano, C., Taddei, M., et al. (2012)Aryl triazole compounds with antitumoural activity. . Brevetto No. WO 2012084602 A1.
Aryl triazole compounds with antitumoural activity
TADDEI, MAURIZIO;FERRINI, SERENA
2012-01-01
Abstract
e present invention relates to aryl triazole derivs. of Formula I having antitumoral activity through, as one possible biol. target, the mol. chaperone heat shock protein 90 (Hsp90) inhibition. The invention includes the use of such compds. in medicine, in relation to cancer disease as well as other diseases where an inhibition of Hsp90 is responsive, and the pharmaceutical compn. contg. such compdsI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/35114
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo